retatrutide cardiovascular TRIUMPH-3 🇦🇺 cardiovascular/obesity clinical trial update : r/RetatrutideTrial retatrutide triple agonist phase 2

This conception has been changing during recent years, since it has been reported that resistance to GIP can be reversed and its effectiveness restored by improving glycemic control

[15] [39] [40] In August 2025, the Food and Drug Administration (FDA) expanded the indication for semaglutide (as Wegovy) to include the treatment of noncirrhotic metabolic-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults

Rating-only entries are displayed without invented customer copy

Hypersensitivity reactions occur in less than 1 in 100 patients